Firms Add XRP to Treasuries Amid Growing Regulatory Clarity
Several publicly traded firms, including Floral Growth Corp, Hyperscale Data Inc., Quantum BioPharma, and Worksport Ltd, have quietly added XRP to their corporate treasuries alongside other holdings such as SOL and ETH. The moves, revealed in recent SEC filings (Forms 6-K, 8-K, and 10-Q), reflect XRP’s enterprise-grade design, low transaction fees, and real-time settlement on the XRP Ledger. Firms cite improved regulatory clarity after a 2023 court ruling that secondary XRP sales are not securities. Quantum BioPharma disclosed 100,000 XRP custodied with BitGo, while Hyperscale Data’s Ault Capital Group acquired $10 million in XRP and will report monthly asset updates. Although corporate XRP positions remain small compared to BTC and ETH, this under-the-radar trend signals growing institutional confidence that could boost demand, support XRP prices, and enhance market liquidity.
Bullish
This news is bullish for XRP because corporate treasury allocations signal growing institutional demand and confidence. In the short term, announcements of fresh XRP holdings often trigger price spikes as traders anticipate increased buy-side pressure. Over the longer term, ongoing monthly reporting commitments and the inclusion of XRP alongside established assets like SOL and ETH indicate a strategic shift toward digital assets, reducing uncertainty and fostering liquidity. Combined with improved regulatory clarity, these developments enhance XRP’s appeal as a treasury asset and could support sustained upward momentum in its market value.